Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2005
08/30/2005US6936249 Proteins producing an altered immunogenic response and methods of making and using the same
08/30/2005US6936247 Filariid anti-P22U antibodies
08/30/2005US6936246 Passive immunization of ASCR for prion disorders
08/30/2005US6936245 Mediators of signal transduction
08/30/2005US6936244 Bacterial infection of the eye can be treated with lytic enzyme produced by bacteria being infected with bacteriophage specific for that bacteria
08/30/2005US6936243 Adeno-associated viral vector-mediated delivery of DNA to cells of the liver
08/30/2005CA2294566C Ikk-.alpha. proteins, nucleic acids and methods
08/30/2005CA2136331C New pharmaceutical uses of krill enzymes
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/30/2005CA2063587C Stable vaccine compositions containing interleukins
08/30/2005CA1341490C Dna functional group and plasmid coding for hirudine, transformed yeast, preparation process for hirudine, resulting hirudine, and its pharmaceutical use
08/30/2005CA1341489C Family of primate hematopoietic growth factors
08/26/2005CA2456595A1 Process for identifying eukariotic tumor cells or bacteria arboring a genomic alteration in at least one part of a gene encoding for a transcription factor
08/25/2005WO2005078848A2 Inhibition of tumor growth and invasion by anti-matrix metalloproteinase dnazymes
08/25/2005WO2005078123A1 Diagnostics and therapeutics for diseases associated with kallikrein 5 (klk5)
08/25/2005WO2005078099A1 Mecp2e1 gene
08/25/2005WO2005078097A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (Multifunctional siNA)
08/25/2005WO2005078094A2 Stabilized rnas as transfection controls and silencing reagents
08/25/2005WO2005078091A1 Induction of apoptosis by inhibition of sirtuin sirt1 expression
08/25/2005WO2005078090A2 Antisense oligonucleotides for treating unwanted pigmentation of the skin and hair
08/25/2005WO2005078077A2 Acid alpha-glucosidase and fragments thereof
08/25/2005WO2005078076A2 Tpl2 and its expression
08/25/2005WO2005078075A2 Hybrid proteins of active-site serine beta-lactamase
08/25/2005WO2005077980A2 Soluble tcr-like molecules and their uses
08/25/2005WO2005077976A2 Coiled-coil domains from c4b-binding protein
08/25/2005WO2005077971A1 Novel heparin-binding peptide designed from heparin-binding site of snake poison-origin vascular endothelial growth factor (vegf)-like protein and use tehreof
08/25/2005WO2005077970A1 Novel heparin-binding peptide designed from heparin-binding site of snake venom-origin vascular endothelial growth factor (vegf)-like protein and use thereof
08/25/2005WO2005077969A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
08/25/2005WO2005077423A2 Adept or gdept producing acetaldehyde
08/25/2005WO2005077421A1 A method of preparing polyethylene glycol modified interferon alpha 1b
08/25/2005WO2005077416A2 Lipid rafts and clostridial toxins
08/25/2005WO2005077415A1 Pharmaceutical composition for treatment of immunological disorders
08/25/2005WO2005077413A1 Ctgf as target for the therapy of diabetic nephropathy
08/25/2005WO2005077411A2 Composition and method for the treatment of carcinoma
08/25/2005WO2005077406A1 Protease inhibitors for the treatment of digestive pathologies
08/25/2005WO2005077405A1 Compositions and methods for the treatment of cancer by systemic elevation of lactate and consequent depletion of arginine
08/25/2005WO2005077404A1 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
08/25/2005WO2005077403A1 Therapeutic methods using smads
08/25/2005WO2005077402A1 Honey based gel formulations
08/25/2005WO2005077401A1 A cardiotonic with active ingredient consist of tripeptide and its derivant
08/25/2005WO2005077400A1 Cysteine rich peptides for improving thiol homeostasis
08/25/2005WO2005077399A1 Preventive and therapeutic agent for chronic obstructive pulmonary disease
08/25/2005WO2005077398A2 Arp for inducing granulocytopoiesis
08/25/2005WO2005077397A2 Methods and compositions for treating vascular diseases
08/25/2005WO2005077349A1 HUMAN β-DEFENSIN PRODUCTION ACCELERATOR
08/25/2005WO2005077338A1 Particles for inhalation rapid release properties
08/25/2005WO2005077337A2 Dispersions prepared by use of self-stabilizing agents
08/25/2005WO2005077093A2 Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
08/25/2005WO2005077084A2 Krüppel-like transcriptional factor klf4/gklf and uses thereof
08/25/2005WO2005077056A2 Methods and compositions for the treatment of inflammation
08/25/2005WO2005077046A2 A composition and method of treating mastitis
08/25/2005WO2005076981A2 Methods and compositions related to neuronal differentiation
08/25/2005WO2005076979A2 Diagnosis and therapeutics for cancer
08/25/2005WO2005076972A2 Chimeric vegf peptides
08/25/2005WO2005076827A2 Fbsa compositions for use in promoting fibrinogen aggregation and potentiating fibrin polymerization
08/25/2005WO2005062918A3 Methods of treating asthma
08/25/2005WO2005059124A3 Isozyme-specific antagonists of protein kinase c
08/25/2005WO2005055945A3 Mucoadhesive drug delivery devices and methods of making and using thereof
08/25/2005WO2005051871A8 Implantable sensors and implantable pumps and anti-scarring agents
08/25/2005WO2005051412A3 Regulation of sperm function
08/25/2005WO2005047537A3 Diagnosis of distal hereditary motor neuropathy type ii by detection of hsp22 gene polymorphisms
08/25/2005WO2005047320A3 Equine p-selection glycoprotein ligand-1 and uses thereof
08/25/2005WO2005042777A3 App/ena antisense
08/25/2005WO2005037868A3 Methods of treating nfat-related disorders
08/25/2005WO2005037194A3 Collagen interactions with prostate cancer cells
08/25/2005WO2005033134A3 Secreted protein therapeutics and uses thereof
08/25/2005WO2005021584A3 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
08/25/2005WO2005021064A3 Delivery of therapeutic compounds to the brain and other tissues
08/25/2005WO2005007108A3 Asymmetric disulfides and methods of using same
08/25/2005WO2004113500A3 B7s1: an immune modulator
08/25/2005WO2004108687A3 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
08/25/2005WO2004098513A3 Nasal administration of the lh-rh analog leuprolide
08/25/2005WO2004089394A3 Treatment of severe acute respiratory syndrome (sars)
08/25/2005WO2004064844A9 Method for inhibition of necrosis induced by neurotrophin
08/25/2005WO2004058292A8 Methods and compositions for suppressing fibrocyte differentiation
08/25/2005WO2003086307A3 β2-MICROGLOBILIN (β2m) AND ANTI-β2m BINDING AGENTS AS ANTI-CANCER THERAPEUTICS
08/25/2005US20050188429 Method for treating a condition with a cytokine of the GP130 subunit signaling family linked to a polynucleotide encoding SOCS-3
08/25/2005US20050188427 Lysyl oxidase-like 1 (LOXL1) and elastogenesis
08/25/2005US20050187718 Novel purified polypeptides from Streptococcus pneumoniae
08/25/2005US20050187639 Soft tissue implants and anti-scarring agents
08/25/2005US20050187600 Electrical devices and anti-scarring agents
08/25/2005US20050187379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/25/2005US20050187200 Methods and reagents for the treatment of inflammatory disorders
08/25/2005US20050187197 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof
08/25/2005US20050187179 treatment of tumors which have increased Notch expression; administration of either Notch antisense oligonucleotides or monoclonal antibodies directed to Notch along with cell differentiating agent
08/25/2005US20050187174 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
08/25/2005US20050187173 A method of delaying the onset of diabetes
08/25/2005US20050187165 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid
08/25/2005US20050187164 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
08/25/2005US20050187163 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences
08/25/2005US20050187162 Novel peptide with osteogenic activity
08/25/2005US20050187161 peptide sequences that selectively bind to fungal surface molecules; Biopanning and Rapid Analysis of Selective Interactive Ligands (BRASIL) provides for rapid and efficient separation of phage that bind to fungal surface molecules
08/25/2005US20050187159 Covalently bonding albumin to oligopeptide; biochemical conjugation; analyzing stability, therapy
08/25/2005US20050187158 comprises erythropoietin (EPO) and a pharmaceutically acceptable diluent, adjuvant, or carrier; to be applied locally and superficially; wound healing agents; alopecia; disease or disorder of the skin or the eye
08/25/2005US20050187157 Pharmaceutical compositions based on anticholinergics and pegsunercept
08/25/2005US20050187156 Isozyme-specific antagonists of protein kinase C
08/25/2005US20050187155 For systematical, local or topical inhibition of metalloproteinases
08/25/2005US20050187154 bone morphogenetic proteins play an important role in adipocyte differentiation; promote brown adipocyte tissue (BAT) differentiation and inhibits white adipose tissue (WAT) adipogenesis
08/25/2005US20050187153 RTVP based compositions and methods for the treatment of prostate cancer, autoimmunity and infectious disease
08/25/2005US20050187152 Prevention and treatment of hypergastrinemia
1 ... 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 ... 3163